La Jolla Pharmaceutical Company Cash and Cash Equivalents 2011-2026 | LJPC

Annual Cash and Cash Equivalents La Jolla Pharmaceutical Company

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
46.7 M	21.2 M	87.8 M	173 M	90.9 M	65.7 M	126 M	48.6 M	8.63 M	3.4 M	5.04 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
173 M	3.4 M	61.6 M

Quarterly Cash and Cash Equivalents La Jolla Pharmaceutical Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	48.3 M	44.2 M	46.7 M	46.8 M	45.9 M	38.6 M	21.2 M	21.2 M	21.2 M	21.2 M	87.8 M	87.8 M	87.8 M	87.8 M	173 M	173 M	173 M	173 M	90.9 M	90.9 M	90.9 M	90.9 M	65.7 M	65.7 M	65.7 M	65.7 M	126 M	126 M	126 M	126 M	48.6 M	48.6 M	48.6 M	48.6 M	8.63 M	8.63 M	8.63 M	8.63 M	3.4 M	3.4 M	3.4 M	3.4 M	5.04 M	5.04 M	5.04 M	5.04 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
173 M	3.4 M	60.7 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
AbbVie ABBV	5.23 B	$ 210.4	-0.34 %	$ 372 B	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	3.22 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Atreca BCEL	30.8 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	38.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	70.5 M	$ 12.84	-8.02 %	$ 1.95 B	USA
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Alnylam Pharmaceuticals ALNY	1.66 B	$ 320.76	-2.25 %	$ 42 B	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	51.8 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	50 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	5.67 M	$ 1.08	-1.06 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	92.7 K	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Equillium EQ	30.3 M	$ 1.99	-3.4 %	$ 114 M	USA
Amgen AMGN	9.13 B	$ 351.45	-0.49 %	$ 189 B	USA
Amphastar Pharmaceuticals AMPH	170 M	$ 19.45	-0.41 %	$ 909 M	USA
Amarin Corporation plc AMRN	135 M	$ 14.42	-1.7 %	$ 5.98 B	Irlanda
Bellerophon Therapeutics BLPH	6.92 M	-	-74.18 %	$ 955 K	USA
ANI Pharmaceuticals ANIP	145 M	$ 73.82	-0.43 %	$ 1.43 B	USA
CRISPR Therapeutics AG CRSP	348 M	$ 46.45	-2.31 %	$ 4.18 B	Schweiz
Arbutus Biopharma Corporation ABUS	18 M	$ 4.33	-2.7 %	$ 830 M	Canada
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA